Publications

5808 Results

Impact of body-mass index in the outcome of adult patients with acute myeloid leukemia

Authors
B Medeiros;M Othus;EH Estey;M Fang;F Appelbaum
Journal / Conference
Haematologica 97(9):1401-1404
Year
2012
Research Committee(s)
Leukemia
PMID
PMID22315487
PMC
PMCID3436242
Study Number(s)
S0106, SWOG-8600, SWOG-9031, SWOG-9126, SWOG-9333, SWOG-9500, S9617, S9918

Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine (PCG) and gemcitabine/cisplatin (GC) in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC intergroup study 30987

Authors
J Bellmunt;H von der Maase;GM Mead;N Skonecza;M DeSantis;G Daugaard;J Heyer;N Houede;L Paz-Ares;L Laufman;E Winquist;D Raghavan;S Marreaud;S Collette;R Sylvester;R de Wit
Journal / Conference
Journal of Clinical Oncology 30(10):1107-1113;
Year
2012
Research Committee(s)
Genitourinary
PMID
PMID22370319
PMC
PMC3341152
Study Number(s)
30987

Design of a phase III clinical trial with prospective biomarker validation: SWOG S0819

Authors
M Redman;J Crowley;R Herbst;F Hirsch;D Gandara
Journal / Conference
Clinical Cancer Research 18(15):4004-4012
Year
2012
Research Committee(s)
Lung
PMID
PMID:22592956
PMC
PMC3409929
Study Number(s)
S0819

Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria [PMID22138096; PMC3260130]

Authors
EA Perez;AC Dueck;A McMullough;M Reinholz;K Tenner;N Davidson;J Gralow;LA Kutteh;DH Hillman;RB Jenkins;B Chen
Journal / Conference
Journal of the National Cancer Institute 104(2):159-162
Year
2012
Research Committee(s)
Breast
Study Number(s)
N9831

IMWG consensus on maintenance therapy in multiple myeloma

Authors
H Ludwig;B Durie;P McCarthy;A Palumbo;J San Miguel;B Barlogie;G Morgan;P Sonneveld;A Spencer;KC Andersen;T Facon;KA Stewart;H Einsele;MV Mateos;P Wijermans;A Waage;M Beksac;PG Richardson;C Hulin;R Niesvizky;H Lokhorst;O Landgren;PL Bergsagel;RZ Orlowski;A Hinke;M Cavo;M Attal
Journal / Conference
Blood 119(13):3003-3015
Year
2012
Research Committee(s)
Myeloma
PMID
PMID22271445
PMC
PMC3321864

Achieving sufficient accrual to address the primary endpoint in phase III clinical trials from U.S. cooperative group trials

Authors
A Schroen;GR Petroni;H Wang;MJ Thielen;R Gray;J Benedetti;XF Wang;DJ Sargent;DL Wickerham;W Cronin;B Djulbegovic;CL Slingluff
Journal / Conference
Clinical Cancer Research 18(1):256-2662
Year
2012
Research Committee(s)
Multiple sites and Outcomes and Comparative Effectiveness

A randomized trial of dasatinib 100 mg vs imatinib 400 mg in newly diagnosed chronic phase chronic myeloid leukemia

Authors
J Radich;K Kopecky;F Appelbaum;S Kamel-Reid;W Stock;G Mainassy;E Paietta;M Wadleigh;R Larson;P Emmanuel;M Tallman;J Lipton;R Turner;B Druker
Journal / Conference
Blood 120(19):3898-3905;
Year
2012
Research Committee(s)
Leukemia
PMID
PMID22915637
PMC
PMC3496952
Study Number(s)
S0325

Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from the intergroup trial CALBG 89803 [PMID22147942; PMC3271172]; https://www.ncbi.nlm.nih.gov/pubmed/22147942

Authors
S Ogino;K Shima;J Meyerhardt;NJ McCleary;K Ng;L Saltz;R Mayer;P Schaefer;R Whittom;A Hantel;A Benson;D Spiegelman;R Goldberg;M Bertagnolli;C Fuchs
Journal / Conference
Clinical Cancer Research 18(3):890-900
Year
2012
Research Committee(s)
Gastrointestinal
Study Number(s)
C89803

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

Authors
R Peto;C Davies;J Godwin;R Gray;H Pan;M Clarke;D Cutter;S Darby;P McGale;C Taylor;YC Yang;J Bergh;A DiLeo;K Albain;S Swain;M Piccart;K Pritchard
Journal / Conference
Lancet 379(9814):432-444
Year
2012
Research Committee(s)
Breast
PMID
PMID22152853
PMC
PMC3273723
Study Number(s)
SWOG-8814

When progressive disease does not mean treatment failure: reconsidering the criteria for progression

Authors
G Oxnard;M Morris;S Hodi;L Baker;A Venook;L Schwartz
Journal / Conference
Journal of the National Cancer Institute 104(20):1534-1541;
Year
2012
Research Committee(s)
Multiple sites
PMID
PMID22927506
PMC
PMC3708548